CNBC August 20, 2024
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
Vaccine makers have set their eyes on the next big thing: Developing combination shots targeting both Covid and the flu.
As Covid vaccination rates in the U.S. dwindle, Pfizer, Moderna and Novavax, among other companies, hope that more convenient combo shots offering protection against two viruses rather than one will increase uptake among Americans. Some health experts have cast doubt on that belief, CNBC previously reported.
Still, combo jabs may also reduce the burden that respiratory viruses — which typically spread at the same time each year — put on pharmacists...
Today's Sponsors
Today's Sponsor